Valuation: Bayer AG

Market Cap 48.58B 55.98B 45.49B 41.61B 78.56B 5,333B 79.58B 532B 209B 2,664B 210B 206B 8,868B P/E 2026 *
21x
P/E 2027 * 16.1x
Enterprise Value 77.79B 89.64B 72.84B 66.63B 126B 8,539B 127B 852B 334B 4,266B 337B 329B 14,200B EV / Sales 2026 *
1.7x
EV / Sales 2027 * 1.62x
Free-Float
100%
Yield 2026 *
0.32%
Yield 2027 * 1.07%
1 day+1.24%
1 week+1.46%
1 month-8.90%
3 months+28.12%
6 months+8.72%
Current year+32.70%
1 week 46.97
Extreme 46.97
50.44
1 month 45.57
Extreme 45.57
52.12
Current year 32.86
Extreme 32.86
53.98
1 year 24.94
Extreme 24.935
53.98
3 years 18.31
Extreme 18.314
53.98
5 years 18.31
Extreme 18.314
67.97
10 years 18.31
Extreme 18.314
123.8
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 60 01/04/2017
Chairman 68 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
+1.24%+1.46% - - 55.83B
+1.89%-1.49%+55.62%+165.18% 1,043B
-0.24%-3.22%+50.51%+52.02% 621B
-0.95%-7.38%+22.83%+65.08% 435B
0.00%+0.83%+42.80%+37.60% 361B
+0.58%-3.51%+31.12%+40.54% 293B
-1.55%-9.78%+5.61%+8.62% 251B
-0.73%+4.44%+34.91%+66.41% 220B
-0.24%-13.15%-4.02%-44.69% 201B
-0.68%-1.41%+16.36%+66.32% 164B
Average -0.04%-3.81%+28.42%+50.79% 398.79B
Weighted average by Cap. +0.28%-3.79%+37.57%+77.18%

Financials

2026 *2027 *
Net sales 45.72B 52.68B 42.81B 39.16B 73.93B 5,019B 74.9B 501B 197B 2,508B 198B 194B 8,346B 46.94B 54.1B 43.96B 40.21B 75.91B 5,153B 76.9B 514B 202B 2,575B 203B 199B 8,570B
Net income 2.17B 2.5B 2.03B 1.86B 3.51B 238B 3.55B 23.75B 9.32B 119B 9.38B 9.17B 396B 2.92B 3.36B 2.73B 2.5B 4.71B 320B 4.78B 31.94B 12.53B 160B 12.61B 12.34B 532B
Net Debt 29.21B 33.66B 27.35B 25.02B 47.23B 3,206B 47.85B 320B 126B 1,602B 126B 124B 5,332B 27.34B 31.51B 25.6B 23.42B 44.21B 3,001B 44.79B 300B 118B 1,500B 118B 116B 4,991B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
31/07/26 48.70 +1.04% 9,552
06/08/26 €49.39 -0.86% 22,535
05/08/26 €49.82 +3.36% 31,125
04/08/26 €48.20 +2.21% 72,526
03/08/26 €47.16 -3.16% 30,894
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
49.22EUR
Average target price
56.81EUR
Spread / Average Target
+15.41%

Quarterly revenue - Rate of surprise